Thomas Erker
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Impaired chloride homeostasis in epilepsy: Molecular basis, impact on treatment, and current treatment approaches.
Journal: Pharmacology & therapeutics
Published: June 03, 2019
Functional characterization of novel bumetanide derivatives for epilepsy treatment.
Journal: Neuropharmacology
Published: May 15, 2019
The role of oxidative stress in 63 T-induced cytotoxicity against human lung cancer and normal lung fibroblast cell lines.
Journal: Investigational new drugs
Published: August 14, 2018
Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain.
Journal: Neuropharmacology
Published: November 16, 2016
A Novel Genistein Prodrug: Design, Synthesis and Bioactivity on Mouse RAW264.7 Macrophages.
Journal: Natural product communications
Published: October 01, 2016
Selective anticancer activity of the novel thiobenzanilide 63T against human lung adenocarcinoma cells.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: March 10, 2016
The search for NKCC1-selective drugs for the treatment of epilepsy: Structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A.
Journal: Epilepsy & behavior : E&B
Published: February 18, 2016
Antiproliferative and Pro-apoptotic Activities of a Novel Resveratrol Prodrug Against Jurkat CD4+ T-Cells.
Journal: Anticancer research
Published: February 07, 2016
Drug trapping in hERG K+ channels: (not) a matter of drug size?
Journal: MedChemComm
Published: October 02, 2015
Last Updated: 09/26/2026